Journal of the Practice of Cardiovascular Sciences

: 2017  |  Volume : 3  |  Issue : 2  |  Page : 127--129

An update on mid-term international society of heart research – Indian section meeting: Cardiovascular research convergence 2017

Sanjay K Banerjee1, Sandeep Seth2,  
1 Drug Discovery Research Centre, Translational Health Science and Technology Institute, Faridabad, Haryana, India
2 Department of Cardiology, All India Institute of Medical Sciences, New Delhi, India

Correspondence Address:
Sanjay K Banerjee
Translational Health Science and Technology Institute, NCR Biotech Cluster, Faridabad - 121 001, Haryana

How to cite this article:
Banerjee SK, Seth S. An update on mid-term international society of heart research – Indian section meeting: Cardiovascular research convergence 2017.J Pract Cardiovasc Sci 2017;3:127-129

How to cite this URL:
Banerjee SK, Seth S. An update on mid-term international society of heart research – Indian section meeting: Cardiovascular research convergence 2017. J Pract Cardiovasc Sci [serial online] 2017 [cited 2023 Mar 27 ];3:127-129
Available from:

Full Text

Dear Editor,

It is estimated that by 2020, cardiovascular disease (CVD) will be the largest cause of disability and death in India, with 2.6 million deaths annually. More than 80% of CVD deaths take place in low- and middle-income countries. Total cost of CVD and stroke are 320.1 billion; this includes health expenditure and loss of productivity. This escalating public health challenge is occurring in the wake of urbanization, surplus energy intake, increasing obesity, and sedentary life habits. While hitherto considered as a “middle-age” disease, the alarming trend seen in recent years is that this disease is now increasingly afflicting the younger population. This again is largely due to altered lifestyles. The scope of the disease and its looming public health implications, therefore, urgently call for the development of early and more sensitive methods for detection, and also for more effective regimens for treatment.

In view of this large and upcoming disease burden, we have organized a 2-day meeting, Cardiovascular Research Convergence (CRC2017) for exchanging research views between clinicians and basic scientists on generating ideas on translational research in cardiovascular medicine on [Figure 1] August 12, 2017 [Figure 2] at the Translational Health Science and Technology Institute (THSTI), Faridabad, and August 20, 2017 at All India Institute of Medical Sciences, New Delhi, respectively [Figure 3].{Figure 1}{Figure 2}{Figure 3}

This meeting was a mid-term activity of International Society of Heart Research (ISHR), Indian Section. The objectives of this meeting were to identify cardiovascular problem in the clinic and finding solutions to prevent the disease. Special emphasis was placed on understanding cardiovascular complication in diabetes, heart failure and its therapy, and role of gut microbiome in CVDs. This meeting brought together experienced as well as novice clinicians [Figure 4] and basic biologists who have a keen interest in the field of cardiovascular biology, including the development of new technologies and methods for evaluating disease progression through different biomarkers. The meeting at THSTI primarily focused on (i) understanding cardiovascular complication in diabetes and identifying newer therapeutic strategies to reduce disease complication, (ii) understanding heart failure in clinic and finding its treatment, and (iii) role of gut microbiome on cardiovascular and metabolic diseases. The meeting at AIIMS discussed various clinical cases where clinicians and basic scientists could interact to provide solutions [Figure 5] and [Figure 6].{Figure 4}{Figure 5}{Figure 6}

Distinguished cardiologists and scientists like Prof. KK Talwar, Prof. NK Ganguly, Prof. Ramesh K Goyal, Prof. P S Reddy, Prof. Subir K Maulik, Prof. Sandeep Seth, Prof. Shinjini Bhatnagar, Prof. S S Kothari, Prof. Uday C Ghoshal, Prof. Anil K Pandey, Prof. Pralay Chakraborty, Prof. Nitish R Mahapatra, Dr. GR Chandak, Dr. Arun Bandyopadhyay, Dr. Shantanu Sengupta, Dr. Rishi Gupta, Dr. SS Bansal, and many others were present and discussed their views [Figure 7].{Figure 7}

CRC2017 at AIIMS was inaugurated by the Director AIIMS, Professor Randeep Guleria who recalled his association with Prof Philip Poole Wilson, Prof Inder Anand and his experiences with research with them at PGI Chandigarh. In the AIIMS CRC2017 conference, faculty from PGI Chandigarh joined in with Prof Ajay Bahl (Cardiology) and Prof Uma Nahar (Pathology). Other speakers from clinical government and private medical institutes and research facilities from Delhi University and IGIB included Dr Ranjeet Nath, Dr Anil Saxena, Dr Sanjay Mittal, Dr Praloy, Dr Sandeep Bansal, Dr Rachna Seth, Dr Sujay Shad, Dr Sridhar and Dr Scaria, Dr S Sengupta, Dr Suman Kundu among many others from AIIMS.

Around 220 researchers and clinicians from more than forty academic institutes, medical institutes, and pharmaceutical industries participated this conference. We have received sixty posters from basic and clinical research from young researchers. Best three posters from basic research and three best posters from clinical research were chosen for further oral presentation to highlight their research work and awarded Torrent ISHR Young Investigator Award. As a direct outcome of this meeting, a good number of scientists and clinicians showed interest to work together to translate cardiovascular research findings from bench to bed and bed to bench. We hope this conference will foster more closeness between clinician and scientist to work together to reduce CVD burden in India.

Financial support and sponsorship


Conflicts of interest

There are no conflicts of interest.